Li, X;
Lai, FTT;
Chua, GT;
Kwan, MYW;
Lau, YL;
Ip, P;
Wong, ICK;
(2022)
Myocarditis Following COVID-19 BNT162b2 Vaccination Among Adolescents in Hong Kong.
JAMA Pediatrics
, 176
(6)
pp. 612-614.
10.1001/jamapediatrics.2022.0101.
Preview |
Text
Wong_ Reduction of myocarditis following the single-dose recommendation of BNT162b2 among adolescents in Hong Kong_VoR.pdf Download (192kB) | Preview |
Abstract
Cases of myocarditis following the second dose of messenger RNA (mRNA) vaccine are accruing worldwide, especially in younger male adults and adolescents.1-4 In weighing the risk of myocarditis against the benefit of preventing severe COVID-19, Norway, the UK, and Taiwan have suspended the second dose of mRNA vaccine for adolescents. Similarly, adolescents (aged 12-17 years) in Hong Kong have been recommended to receive 1 dose of BNT162b2 instead of 2 doses 21 days apart since September 15, 2021 (Figure).
Archive Staff Only
 |
View Item |
